Avricore Health (AVCRF) Profit After Tax Growth (3y) (2012 - 2026)
Avricore Health (AVCRF) Profit After Tax Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.70 Bn | 209.63 Bn | 8.34 Bn | 8.53% |
| 2 | Danaher | 140.15 Bn | 135.80 Bn | 3.61 Bn | -1.85% |
| 3 | Idexx Laboratories | 46.31 Bn | 46.11 Bn | 779.09 Mn | 14.70% |
| 4 | Agilent Technologies | 39.74 Bn | 37.93 Bn | 990.00 Mn | 3.93% |
| 5 | Iqvia Holdings | 39.38 Bn | 37.30 Bn | 1.44 Bn | -4.58% |
| 6 | Natera | 38.78 Bn | 37.68 Bn | 696.04 Mn | 13.70% |
| 7 | Illumina | 29.96 Bn | 28.79 Bn | 770.00 Mn | 42.35% |
| 8 | Mettler Toledo International | 28.60 Bn | 28.55 Bn | 650.22 Mn | 6.28% |
| 9 | Quest Diagnostics | 26.26 Bn | 25.64 Bn | 1.03 Bn | 10.28% |
| 10 | Avricore Health | 3.04 Mn | 3.01 Mn | -6,202.70 | 11.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.21% |
| Dec 31, 2025 | 12.96% |
| Sep 30, 2025 | -58.62% |
| Jun 30, 2025 | -59.27% |
| Mar 31, 2025 | 28.35% |
| Sep 30, 2024 | 27.74% |
| Jun 30, 2024 | 37.24% |
| Mar 31, 2024 | 30.48% |
| Dec 31, 2023 | 28.18% |
| Sep 30, 2023 | -11.07% |
| Jun 30, 2023 | -13.98% |
| Mar 31, 2023 | 6.26% |
| Dec 31, 2022 | -43.01% |
| Sep 30, 2022 | 31.47% |
| Jun 30, 2022 | 34.06% |
| Mar 31, 2022 | 26.97% |
| Dec 31, 2021 | 51.93% |
| Sep 30, 2021 | 12.58% |
| Jun 30, 2021 | 23.28% |
| Dec 31, 2020 | 23.89% |